Company intelligence / Profile preview

Neuradom

Ownership: Private
Development stage: Other

Overview

Neuradom operates a digital health platform that combines teleconsultation with the prescription of personalized self-rehabilitation exercises. The company aims to improve access to rehabilitation services by leveraging technology for remote care delivery. Clinical results are not specified; the focus is on service provision rather than clinical trials or drug development.

Therapeutic areas: NeurologyOther
Modalities: Non-pharmacological therapyDigital therapeutic platform (teleconsultation and self-rehabilitation exercises)
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Neuradom.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuradom.

Explore the full profile